Bomedemstat in ET
Phase IIb Trial of LSD1 Inhibitor Bomedemstat in Patients With Essential Thrombocythemia Resistant or Intolerant to Standard Therapy

Released: December 13, 2023

Activity

Progress
1
Course Completed